v3.25.4
The Charles Schwab Corporation – Parent Company Only Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities      
Net income $ 8,852 $ 5,942 $ 5,067
Adjustments to reconcile net income to net cash provided by (used for) operating activities:      
Other 729 552 702
Net change in:      
Other assets (1,298) 92 (1,569)
Payables to brokers, dealers, and clearing organizations 12,353 6,688 1,808
Accrued expenses and other liabilities (192) 218 3,048
Net cash provided by (used for) operating activities 9,311 2,670 19,587
Cash Flows from Investing Activities      
Purchases of available for sale securities (8,496) (2,986) (1,487)
Proceeds from sales of available for sale securities 8,987 3,532 8,465
Principal payments on available for sale securities 22,958 25,589 36,508
Other investing activities (370) (322) (287)
Net cash provided by (used for) investing activities 24,538 35,431 57,411
Cash Flows from Financing Activities      
Repurchases of common stock and nonvoting common stock (7,346) 0 (2,842)
Redemption and repurchase of preferred stock (2,458) 0 (467)
Dividends paid (2,329) (2,275) (2,276)
Proceeds from stock options exercised 156 84 49
Net cash provided by (used for) financing activities (29,702) (47,060) (61,245)
Increase (Decrease) in Cash and Cash Equivalents 4,147 (8,959) 15,753
Cash and Cash Equivalents, including Amounts Restricted at Beginning of Year 65,514 [1] 74,473 [1] 58,720
Cash and Cash Equivalents, including Amounts Restricted at End of Year [1] 69,661 65,514 74,473
Parent Company      
Cash Flows from Operating Activities      
Net income 8,852 5,942 5,067
Adjustments to reconcile net income to net cash provided by (used for) operating activities:      
Dividends in excess of (equity in undistributed) earnings of subsidiaries 3,896 (3,838) (1,318)
Other (6) (64) (35)
Net change in:      
Other assets 28 (175) (106)
Payables to brokers, dealers, and clearing organizations 3 0 0
Accrued expenses and other liabilities 161 31 77
Net cash provided by (used for) operating activities 12,934 1,896 3,685
Cash Flows from Investing Activities      
Due from (to) subsidiaries — net 300 862 (174)
Return of (increase in) investments in subsidiaries 187 2,205 (2,720)
Repayments (advances) of subordinated loan to CS&Co (750) 0 0
Purchases of available for sale securities (4,475) (2,985) (1,486)
Proceeds from sales of available for sale securities 1,469 1 0
Principal payments on available for sale securities 3,003 3,048 3,721
Other investing activities (53) (24) (7)
Net cash provided by (used for) investing activities (319) 3,107 (666)
Cash Flows from Financing Activities      
Proceeds from short-term borrowings 3,865 0 344
Repayments of short-term borrowings (2,055) 0 (598)
Issuances of long-term debt 1,986 0 6,097
Repayments of long-term debt (2,143) (3,600) (800)
Repurchases of common stock and nonvoting common stock (7,346) 0 (2,842)
Redemption and repurchase of preferred stock (2,458) 0 (467)
Dividends paid (2,329) (2,275) (2,276)
Proceeds from stock options exercised 156 84 49
Net cash provided by (used for) financing activities (10,324) (5,791) (493)
Increase (Decrease) in Cash and Cash Equivalents 2,291 (788) 2,526
Cash and Cash Equivalents, including Amounts Restricted at Beginning of Year 10,538 11,326 8,800
Cash and Cash Equivalents, including Amounts Restricted at End of Year $ 12,829 $ 10,538 $ 11,326
[1] For more information on the nature of restrictions on restricted cash and cash equivalents, see Note 23.